Interferon linked to ER+/HER- metastatic breast cancer resistance to therapy
Both preclinical models and tumor samples from patients with ER+/HER2- breast cancer link high IFN signaling to resistance to treatment.
Read MoreBoth preclinical models and tumor samples from patients with ER+/HER2- breast cancer link high IFN signaling to resistance to treatment.
Read MoreDr. Meagan Pitcher shared her transition from biomedical research to licensing, the nuances of her work and how she keeps in shape.
Read MoreResearchers identified proteomic signatures associated with clinical measures of aggressive disease for each of the seven cancer types studied.
Read MoreWhat is transparent, as long as a credit card is thick and helps solve science mysteries? The laboratory worm, C. elegans.
Read MoreDr. Debra Murray shared her professional journey, from conducting basic science research to developing and managing programs to interest minority students in genomics.
Read MoreDr. Darius Dawson shared his dedication to improving the health of minority populations, a hint to his artistic side and much more.
Read MoreDr. Kathryn Jones shared how she discovered her vocation, how she unwinds at the end of the day and much more.
Read MoreInhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.
Read MoreBy taking a close look inside mesothelioma, Dr. B. Burt searches for clues to predict patient’s response to immunotherapy.
Read MoreVariation of human immune response to RSV reinfection suggests it is important to consider this variation in vaccine design.
Read More